Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-07 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
70,961 | $15.91 | $1,128,642 | 117,566 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:06 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
140,372 | $15.8 | $2,217,407 | 191,665 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
62,250 | $16.06 | $999,425 | 124,503 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-13 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
98,943 | $17.3 | $1,711,447 | 0 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 4:20 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
48,629 | $13.52 | $657,240 | 121,519 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 4:21 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
95,762 | $13.34 | $1,277,207 | 405,392 (Direct) |
View |
| 2024-02-28 Sale |
2024-03-01 06:43 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,599 | $13.12 | $270,176 | 69,770 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
72,009 | $9.5536 | $687,949 | 69,770 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:33 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
44,252 | $9.8866 | $437,502 | 90,369 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
58,952 | $7.4382 | $438,494 | 260,879 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:41 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $8.1422 | $167,713 | 61,477 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
13,135 | $9.0605 | $119,010 | 63,638 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
7,513 | $10.58 | $79,521 | 142,425 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 4:01 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
993 | $10.88 | $10,803 | 11,873 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $10.85 | $223,507 | 72,560 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
68,422 | $12.72 | $870,389 | 23,900 (Direct) |
View |
| 2020-09-09 Sale |
2020-09-10 09:04 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
333 | $8.9844 | $2,992 | 10,765 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-05 Exercise |
2025-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
22,576 | $0 | 117,566 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
69,182 | $0 | 117,566 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
237,142 | $0 | 191,665 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
62,250 | $0 | 124,503 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
183,169 | $0 | 183,169 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-07 4:20 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
77,802 | $0 | 121,519 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:21 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
95,762 | $0 | 405,392 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:21 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
81,845 | $0 | 405,392 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:43 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,599 | $0 | 69,770 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 07:28 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
55,226 | $0 | 55,226 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
72,009 | $0 | 536,470 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
249,003 | $0 | 536,470 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
70,840 | $0 | 90,369 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:01 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
50,242 | $0 | 50,242 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
81,854 | $0 | 260,879 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
134,048 | $0 | 260,879 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:41 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $0 | 61,477 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
13,135 | $0 | 63,638 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
43,358 | $0 | 63,638 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
15,920 | $0 | 142,425 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
90,304 | $0 | 142,425 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:01 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
2,101 | $0 | 11,873 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $0 | 72,560 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
13,135 | $0 | 23,900 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
55,287 | $0 | 23,900 (Direct) |
View |
| 2020-09-09 Exercise |
2020-09-10 09:04 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
698 | $0 | 10,765 (Direct) |
View |